Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Christian Focan"'
Autor:
Cindy Kenis, Lore Decoster, Johan Flamaing, Philip R. Debruyne, Inge De Groof, Christian Focan, Frank Cornélis, Vincent Verschaeve, Christian Bachmann, Dominique Bron, Heidi Van den Bulck, Dirk Schrijvers, Christine Langenaeken, Pol Specenier, Guy Jerusalem, Jean-Philippe Praet, Jessie De Cock, Jean-Pierre Lobelle, Hans Wildiers, Koen Milisen
Publikováno v:
BMC Geriatrics, Vol 22, Iss 1, Pp 1-14 (2022)
Abstract Background Falls and fall-related injuries are a major public health problem. Data on falls in older persons with cancer is limited and robust data on falls within those with a frailty profile are missing. The aim of this study is to investi
Externí odkaz:
https://doaj.org/article/bf52381393b7483d81bf534bf0fcbe9e
Autor:
Pasquale F. Innominato, Annabelle Ballesta, Qi Huang, Christian Focan, Philippe Chollet, Abdoulaye Karaboué, Sylvie Giacchetti, Mohamed Bouchahda, René Adam, Carlo Garufi, Francis A. Lévi
Publikováno v:
Cancer Medicine, Vol 9, Iss 12, Pp 4148-4159 (2020)
Abstract The least toxic time (LTT) of irinotecan varied by up to 8 hours according to sex and genetic background in mice. The translational relevance was investigated within a randomized trial dataset, where no LTT stood out significantly in the who
Externí odkaz:
https://doaj.org/article/2990600537df42ceb50e3ef287e9b467
Autor:
Jacques De Grève, Jan Van Meerbeeck, Johan F Vansteenkiste, Lore Decoster, Anne-Pascale Meert, Peter Vuylsteke, Christian Focan, Jean-Luc Canon, Yves Humblet, Guy Berchem, Benoit Colinet, Danny Galdermans, Lionel Bosquée, Joanna Vermeij, Alex Dewaele, Caroline Geers, Denis Schallier, Erik Teugels
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0147599 (2016)
INTRODUCTION:Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibition is the preferred first-line treatment of advanced adenocarcinoma of the lung that harbors EGFR activating tyrosine kinase domain mutations. Most data available pertain to
Externí odkaz:
https://doaj.org/article/d77d90c2874a41ca9219fe0d09d1012a
Autor:
Wildiers, Victoria Depoorter, Katrijn Vanschoenbeek, Lore Decoster, Geert Silversmit, Philip R. Debruyne, Inge De Groof, Dominique Bron, Frank Cornélis, Sylvie Luce, Christian Focan, Vincent Verschaeve, Gwenaëlle Debugne, Christine Langenaeken, Heidi Van Den Bulck, Jean-Charles Goeminne, Wesley Teurfs, Guy Jerusalem, Dirk Schrijvers, Bénédicte Petit, Marika Rasschaert, Jean-Philippe Praet, Katherine Vandenborre, Harlinde De Schutter, Koen Milisen, Johan Flamaing, Cindy Kenis, Freija Verdoodt, Hans
Publikováno v:
Cancers; Volume 15; Issue 13; Pages: 3349
This study aims to describe end-of-life (EOL) care in older patients with cancer and investigate the association between geriatric assessment (GA) results and specialized palliative care (SPC) use. Older patients with a new cancer diagnosis (2009–2
Autor:
Sylvie Giacchetti, Carlo Garufi, Pasquale F. Innominato, Christian Focan, Angela Torsello, Abdoulaye Karaboué, Ayhan Ulusakarya, René Adam, Francis Lévi, Philippe Chollet, Mohamed Bouchahda
Publikováno v:
International Journal of Cancer. 148:2512-2521
The triplet combination of irinotecan, oxaliplatin and fluorouracil is an active frontline regimen in metastatic colorectal cancer, but scarce data exist on its use as salvage treatment. We aimed at assessing its safety and efficacy profiles with its
Autor:
Philippe Chollet, Pasquale F. Innominato, Mohamed Bouchahda, Annabelle Ballesta, Abdoulaye Karaboué, Sylvie Giacchetti, Francis Lévi, Christian Focan, Carlo Garufi, Qi Huang, René Adam
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 12, Pp 4148-4159 (2020)
Cancer Medicine, Vol 9, Iss 12, Pp 4148-4159 (2020)
The least toxic time (LTT) of irinotecan varied by up to 8 hours according to sex and genetic background in mice. The translational relevance was investigated within a randomized trial dataset, where no LTT stood out significantly in the whole popula
Autor:
Glen Meert, Cindy Kenis, Koen Milisen, Philip R. Debruyne, Inge De Groof, Christian Focan, Frank Cornélis, Vincent Verschaeve, Christian Bachmann, Dominique Bron, Heidi Van Den Bulck, Dirk Schrijvers, Christine Langenaeken, Pol Specenier, Guy Jerusalem, Jean-Philippe Praet, Jean-Pierre Lobelle, Johan Flamaing, Hans Wildiers, Lore Decoster
Publikováno v:
Journal of Geriatric Oncology
Introduction: Functional status (FS) and frailty are significant concerns for older adults, especially those with cancer. Data on FS (Activities of Daily Living [ADL]; Instrumental Activities of Daily Living [IADL]) and its evolution during cancer tr
Autor:
Stephanie Marechal, Christian Focan, Eugene Mutijima, Pierre Reginster, Arvne Servais, Antoine de Muylder
Publikováno v:
Anti-cancer drugs. 33(2)
The authors present the case of a 94-year-old woman suffering from a right arm angiosarcoma developed after primary breast cancer and treated with success by oral metronomic chemotherapy based on daily low doses of cyclophosphamide and prednisone. Th
Autor:
Pasquale F, Innominato, Abdoulaye, Karaboué, Christian, Focan, Philippe, Chollet, Sylvie, Giacchetti, Mohamed, Bouchahda, Ayhan, Ulusakarya, Angela, Torsello, René, Adam, Francis A, Lévi, Carlo, Garufi
Publikováno v:
International Journal of Cancer
The triplet combination of irinotecan, oxaliplatin and fluorouracil is an active frontline regimen in metastatic colorectal cancer, but scarce data exist on its use as salvage treatment. We aimed at assessing its safety and efficacy profiles with its
Autor:
Veronique Raskin, Geoffrey Brands, Philippe Evrard, Stephanie Marechal, Marie-Pascale Graas, Christian Focan, Jean-Pierre Lobelle, Ludivine Collard, Morgan Collin
Publikováno v:
Anticancer research. 40(8)
Background/aim A prospective non-randomized study was performed on 68 women who had recently undergone curative treatment (surgery +/- adjuvant radio/chemotherapy) for breast cancer. Patients and methods Patients were distributed into 2 subgroups, co